Some of the current team took part when the system’s predecessor saved seven Russian sailors from a submarine entangled in ...

Minecraft 26.1 Tiny Takeover game drop has finally been officially released by Mojang. This is a relatively small update compared to other game drops since it only adds a golden dandelion that can ...

Saber Interactive released a new hotfix for Warhammer 40,000: Space Marine 2, and while it doesn’t bring any new content, it does apply balance changes to perks and more. Console gamers will see this ...

A Structure Therapeutics obesity pill helped patients lose an average of nearly 40 pounds in a mid-stage clinical trial, keeping the drug competitive in the growing crowd of oral medications pursuing ...

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Minecraft Aether 2 mod is one of the oldest and most popular third-party features ever. It is a sequel to the original Aether mod that was released in 2011. The first mod added a brand new heaven-like ...

This log tiny prefab house is filled with all types of beautiful wood and offers the ultimate setup for a tiny house! The manufacturer for this modular house is in partners with Hilltop Structures ...

The MK54 MOD 2 is an advancement over the MK54 MOD 0 and MOD 1, with a more advanced and lethal warhead, and enhanced target tracking and classification system. Northrop Grumman announced on Jan. 12, ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics (GPCR) delivered robust Phase 2b results for aleniglipron, surpassing key efficacy and tolerability thresholds for oral GLP-1 therapies. GPCR now appears competitive with top ...